We bring, not only our own experience to an engagement, but, as noted to the right, the experience of a deep network of collaborators across a range of technical domains in therapeutics, diagnostics, and medical devices.
Colin has thirty years of experience as a public and private life science company Chairman, Executive Chairman, Board Member, CEO, and entrepreneur with leadership experience across the R&D-commercial continuum in therapeutics, diagnostics, and medical devices. He has led multi-billion-dollar, midsized, small, and start-up life science companies in the USA, Canada, United Kingdom/Ireland, and Israel. He is CEO and Managing Director of iSci Management LLC, a life science strategic advisory firm.
Colin began his career in pharmaceutical marketing & sales ultimately becoming President & CEO of Bayer AG's North American Pharmaceutical Division and a member of the Global Pharmaceutical Operating Committee, following which he co-founded and was board member and CEO of Optherion Inc, a venture-backed biotechnology company. Subsequently, he was Executive Chairman of Ivenix Inc, a venture-backed medical device company, and board member and CEO of Bioblast Pharma Inc, a publicly traded biotechnology company.
Colin has a B.Sc. in Zoology and Microbiology from the University of Toronto, an M.B.A. from the Ivy School of Business, Western University in Canada, and his Canadian Securities Certificate. He is a citizen of the USA, Canada, and United Kingdom.